Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease.

NCT01117948 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
219
Enrollment
OTHER
Sponsor class

Stopped Lack of Efficacy

Conditions

Interventions

Sponsor

JSW Lifesciences